Navigation Links
Lilly Announces Termination of AIR Insulin Program
Date:3/7/2008

INDIANAPOLIS, March 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced the termination of development of its AIR(R) Insulin program, which was being conducted in partnership with Alkermes, Inc. The program has been in phase III clinical development as a potential treatment for type 1 and type 2 diabetes. The company noted that this decision is not a result of any observations during AIR Insulin trials relating to the safety of the product, but rather was a result of increasing uncertainties in the regulatory environment, and a thorough evaluation of the evolving commercial and clinical potential of the product compared to existing medical therapies.

"This decision, though difficult, is the right one to make at this time," commented John Lechleiter, Ph.D., Lilly president and chief operating officer. "Over the past several months we have conducted a thorough review of all aspects of our efforts to develop our AIR Insulin product and have now made the decision that it would be inappropriate for the company to continue development activities in connection with this project. Without the prospect of a new drug application, keeping the patient foremost in mind, it would not be consistent with our medical principles to continue the clinical trials. As a result, we are now beginning the process of halting our ongoing clinical studies and transitioning the AIR Insulin patients in these studies to other appropriate therapies. We wish to reassure patients currently receiving AIR Insulin in our ongoing clinical trials that they should have no health or safety concerns about continuing to use AIR Insulin during their transition to other well-established diabetes therapies."

Steven M. Paul, M.D., executive vice p
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...RNewswire/ -- Marrone Bio Innovations (MBI), a lea...ation of effective and environmentally responsible...een named an IC20 company by the Investors, Circle...ngel investing group. ,, Companies named to the...sults for all stakeholders, including investors, t...
(Date:11/18/2009)... able to find explosive materials and persons who ...es, the National Institute of Standards and Techno...omeland Security, has developed a new certified re...) 2905, Trace Particulate Explosives. Compatible w...ll be helpful in calibrating, testing and developi...
(Date:11/18/2009)...Belfast are developing new sensors to detect chemi...e fight against the threat of terrorist attacks. ,..., an individual or crime scene to gather a sample ...at can detect the presence of chemicals within sec...be made in response to terrorist threats. , The...
(Date:11/18/2009)...in data analysis combined with Bio-Rad,s Biote...rricula provide state-of-the-art solutions to biot...18 Vernier Software & Technolo...sensors, and software and Bio-Rad Laboratories, In...f life science research and clinical diagnostics p...
Breaking Biology Technology:Marrone Bio Innovations Named an IC20 Company 2New NIST trace explosives standard slated for homeland security duty 2New technology detects chemical weapons in seconds 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
..., NERVIANO, Italy, May 13 The FDA has approve... Nerviano Medical Sciences to,begin a phase I clin...,inhibitor for the treatment of cancer. PLK-1 is a...cancer cells. This new compound is orally bioavail...nical models of cancer after,repeated dosing. This...
..., CAMBRIDGE, Mass., May 13 Xennex, Inc. (Xennex) ... the release of Version 3.0 beta, available at ...ards Version 3.0 features a significantly upgraded...nal biological database, and a novel, sophisticate...ties for highly effective and well-targeted querie...
..., Study Presented at the Pediatric Academic Societ...archers Shows a Statistically-Significant Associat... , IRVINE, Calif., May 13 /PRNewswire-FirstCall...ulse CO-Oximetry(TM) and Measure-Through Motion an...at a new clinical study conducted in the Emergency...
Other Biology Technology:Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor 2GeneCards(R) Version 3.0 Beta Released 2GeneCards(R) Version 3.0 Beta Released 3New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children 2New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children 3New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children 4New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children 5
(Date:11/19/2009)..., which cultivate fungus for food, have many remar...he list: the ant farmers, like their human counter...their gardens grow. The finding, reported this wee...previously unknown symbiosis between ants and bact...s have come to dominate the American tropics and s...
(Date:11/19/2009)...p in many countries of the world. It is widely use...al materials. It also is considered an exemplar pl...evolution, and genome architecture. The authors of... used the first description of the B73 maize genom...n genetics and plant biology. The ten papers consi...
(Date:11/19/2009)... A four-year, multi-institutional effort co-led b...tists culminated today in publication of a landmar...ing in unprecedented detail the DNA sequence of ma...y called by North American consumers, is one of th...ble agricultural crop grown in the United States, ...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Moderate amounts of protein per meal found best for building muscle 10531 1Moderate amounts of protein per meal found best for building muscle 10531 2Slipper shaped blood cells 10529 1Liposuctioned Fat Can Be Used for Breast Augmentation 60104 1Liposuctioned Fat Can Be Used for Breast Augmentation 60104 2
...ts at the National Institute of Arthritis and Musc... National Institutes of Health in Bethesda, Md., a...rlottesville have succeeded in imaging, in unprece... A team of researchers led by NIAMS, Alasdair Stev...H3N2 strain of influenza A virus, has been able to...
...Takesha Henderson,s discoveries are named Charlott...omology. Her graduate studies at Texas A&M Uni...s in Brazos County and one species found for the f... National Science Foundation, Henderson, who is ea...spider diversity, distribution and abundance in th...
...ist at Washington University in St. Louis and his ...ian brain cells that keeps cells in synchrony so t...ecretion and loco motor behaviors are coordinated ... Washington University associate professor of Biol...aduate student in Herzog’s lab who is now a postd...
Other Biology News:Ground spider diversity studied in research project 2Protein shown to rally biological clock 2
Hae III from Takara Mirus Bio
Sma I (High Concentration) from Takara Mirus Bio
BamH I from New England Biolabs
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
Biology Products: